Manufacturer, Services
Ind-Swift Ltd.
Claim Your Company
India,Delhi
Average Lead Time: 17 days
Annual Revenue: Above US$100 Million
Membership Year: 1887
Plant Area:
5,000-10,000 square meters
Accepted Payment Modes:
USD, JPY, CNY
Certification:
BSCI, BSCI
Main Products:
Pharmacueitical Medicines, formaulation
We are pleased to introduce Ind-Swift Ltd, public listed company in Indian Stock market as one of the fastest growing pharmaceutical company of India. Ind-Swift is committed to build long lasting associations through the strategic selection of products, partners and markets. Today Ind-Swifts market reach spans over 70 countries across five continents as it serves discerning customers in Africa, Australia, Asia, Europe, Latin America & Central America, the middle east & CIS.Ind-Swift Ltd. established in year 1984, Ind-Swift is one of the leading Indian manufacturer and exporter of APIs and Formulations. Kindly visit our website www.gbu.indswift.com. The turnover of Ind-Swift conglomerate expected to reach USD 475 million in financial year 2014-2015. Ind-Swift group is engaged in manufacturing, marketing and exports of APIs and Finished Formulations.Please note that our plant is approved by MHRA UK, TGA Australia, ANVISA Brazil, GCC Saudi Arabia, MOH Dubai and other African countries.
